Sort By:

Chikungunya Vaccine Study

Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the Chikungunya vaccine in healthy adolescents between the ages of 12 and 17 years old. The study will last approximately 6 months with 7 visits to our office. Compensation is available for up to $650 for time and travel, for those who qualify.

View Trial Details
Ages 12 - 17
Compensation* $650
Study Topics Chikungunya Virus

*Compensation for time and travel may be available to those who qualify.